DFTX

Definium Therapeutics, Inc.

NASDAQ: DFTX · HEALTHCARE · BIOTECHNOLOGY

$36.17

-1.52% today

Updated 2026-09-25

Market cap

$5.23B

P/E ratio

—

P/S ratio

—

EPS (TTM)

$-3.43

Dividend yield

—

52W range

$9 – $50

Volume

2.1M

Market cap

$5.23B

P/E ratio

—

P/S ratio

—

EPS (TTM)

$-3.43

Dividend yield

—

52W range

$9 – $50

Volume

2.1M

WallStSmart proprietary scores

out of 100

Grade: F

Strong Sell

Investment rating

4.3

Growth

7.3

Quality

B+

3.0

Profitability

5.0

Valuation

C+

2/9

Piotroski F-Score

Weak

—

Altman Z-Score

—

Industry rank

—

View all highly rated stocks (75+) →260 stocks currently score above 75

Price targets

Analyst target

$67.47

+86.54%

12-Month target

—

Intrinsic (DCF)

—

Margin of safety

—

4 Strong Buy14 Buy0 Hold0 Sell0 Strong Sell

Price chart

Stock snapshot

Strengths

+ Debt/equity 0.04x — low leverage

Risks

- Piotroski 2/9 — weak financial health

- Thin margins at 0.00%

- Negative free cash flow $-52.78M

Key financials

Revenue Net Income Free Cash Flow

Metric	2022	2023	2024	2025	TTM
Revenue	$0.00	$0.00	$0.00	$0.00	$0.00
Net income	$-56.80M	$-95.73M	$-108.68M	$-183.79M	$-158.99M
EPS	—	—	—	—	$-3.43
Free cash flow	$-50.14M	$-64.36M	$-79.13M	$-131.56M	$-52.78M
Profit margin	—	—	—	—	—

Peer comparison

Company	Mkt Cap	Score	Growth	Profit	Value	Quality	MoS	Rating
DFTX	$5.23B	25	4.3	3.0	5.0	7.3	—	Avoid
LLY	$1.03T	76	9.3	10.0	5.0	6.0	—	Strong Buy
JNJ	$648.67B	59	4.7	8.5	3.7	5.5	—	Buy
ABBV	$454.36B	73	6.7	8.5	4.0	5.0	-73.51%	Strong Buy
MRK	$365.34B	36	4.0	4.5	2.0	5.0	-78.20%	Hold
UNH	$333.27B	62	7.3	5.5	5.3	5.5	-14.85%	Buy

Smart narrative

Definium Therapeutics, Inc. trades at $36.17. Our Smart Value Score of 25/100 indicates the stock is weak. The company scores 2/9 on the Piotroski F-Score.

Frequently asked questions

What is Definium Therapeutics, Inc.'s stock price?

Definium Therapeutics, Inc. (DFTX) trades at $36.17.

Is Definium Therapeutics, Inc. overvalued?

Definium Therapeutics, Inc. carries a Smart Value Score of 25/100 (Grade F), which we rate Strong Sell. That score blends growth, quality, and valuation into one read.

What is the price target of Definium Therapeutics, Inc. (DFTX)?

The 12-month analyst consensus target is $67.47, about 86.5% above the current $36.17. A consensus target is the average of Wall Street's 12-month forecasts, so it works as a sentiment gauge rather than a guarantee, and it resets with every earnings cycle.

Company info

SectorHEALTHCARE

IndustryBIOTECHNOLOGY

CountryUSA

ExchangeNASDAQ

CurrencyUSD

Quick metrics

P/S ratio—

ROE-85.19%

Beta2.24

50D MA$43.13

200D MA$25.47

Shares out0.13B

Float0.12B

Short ratio—

Avg volume2.1M

Performance

1 week—

1 month—

3 months—

YTD—

1 year—

3 years—

5 years—

Compare

DFTX vs LLY →DFTX vs JNJ →DFTX vs ABBV →Stock screener →